Exicure XCUR
NASDAQ XCUR
$1.15 -0.15 (-11.54%)
As of: Aug 21, 2026 · 3:59 PM EDT

Exicure (XCUR) Operating Margin Growth (3y) (2019 - 2024)

Exicure (XCUR) Operating Margin Growth (3y) (2019 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -204.00
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -537.00
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 9,003.00
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -11,254.00
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.27 Bn 26.43 Bn - -2,649.00
10 Exicure 7.27 Mn 7.27 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2024 105,216.00
Dec 31, 2022 334,636.00
Sep 30, 2022 87,009.00
Jun 30, 2022 84,555.00
Mar 31, 2022 2.20 Mn
Dec 31, 2021 8.18 Mn
Sep 30, 2021 965,825.00
Jun 30, 2021 1.30 Mn
Mar 31, 2021 1.35 Mn
Dec 31, 2020 -874,177.00
Jun 30, 2020 1,021.00
Mar 31, 2020 10,787.00
Dec 31, 2019 -167,870.00